Project Number 5P50AG005146-29 Agency/Funding Organization NIA Funding Year 2012 View Full Project Details for MODELING AND ANTI-AMYLOID THERAPY FOR AD: POTENTIAL FOR COGNITIVE RECOVERY Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) a. Amyloid beta Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator SAVONENKO, ALENA Principal Investigator First Name ALENA Principal Investigator Last Name SAVONENKO Awardee Organization JOHNS HOPKINS UNIVERSITY Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-10-002: ALZHEIMER'S DISEASE RESEARCH CENTERS (P50) FY Overall Cost $225,677 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) Johns Hopkins University Alzheimer's Disease Center National Alzheimer's Coordinating Center (NACC) [AlzPED] Limited clearance of pre-existing amyloid plaques after intracerebral injection of Abeta antibodies in two mouse models of Alzheimer disease.
